TMPO and neoplasm: Given TP5’s pentapeptide composition (arginyl-lysyl-aspartyl-valyl-tyrosine) and the established roles of these constituent amino acids in T cell biology [13], we hypothesized that the effect of TP5 in controlling tumor progression operates through T cell-mediated antitumor mechanisms.